Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
  • Overview
  • Insights
  • Recognition

About Jasmine

Jasmine M. De Cock is an associate in the Munich office of Fish & Richardson P.C.  Prior to joining the firm, Dr. De Cock earned her Ph.D. in biology from Dr. Robert Weinberg’s laboratory at the Whitehead Institute for Biomedical Research/Massachusetts Institute of Technology (MIT), where she investigated the role of inflammation in the awakening of dormant disseminated cancer cells.  Dr. De Cock has experience working in both the pharmaceutical research industry as well as in academia.  As part of her undergraduate degree at King’s College of London (U.K.), Dr. De Cock was an industrial placement student at Pfizer in Sandwich, U.K., where she worked in a multi-disciplinary group on high-throughput assay development.

Dr. De Cock’s practice focuses on patent prosecution and counseling in the life sciences (including cancer biology, cellular and molecular biology immunology, biochemistry, and molecular genetics). She manages US and foreign patent portfolios and has experience with due diligence studies and opinions regarding validity and infringement issues. She has also assisted clients in obtaining patents claiming inventions such as recombinant protein manufacturing, nucleic acid vectors, recombinant nucleic acids and proteins, antibodies, methods of treatment, vaccines, gene therapies, CRISPR therapeutics, CAR T-cell therapies, and screening and diagnostic assays and kits. In 2015, Dr. De Cock was an intern in the Boston office of Fish & Richardson as part of the MIT Alumni Association Externship Program.

As 1L at Columbia Law School, Dr. De Cock participated in the 1L Leadership Council on Legal Diversity (LCLD) Scholars Program. Dr. De Cock was the recipient of the 2020 NY IP Law Education Foundation (NYIPLEF) Diversity Scholarship.

Publications

  • “LACTB is a tumour suppressor that modulates lipid metabolism and cell state.” Nature (March 2017: 543(7647): 681-686)
  • Dance Partners Janssen and Celltrion Face Off in Trial Scheduled for February 2017,” Fish Litigation Blog (February 7, 2017)
  • “Inflammation triggers Zeb1-dependent escape from tumor latency,” Cancer Research (2016 Dec 1;76(23):6778-6784)
  • “Neutrophils suppress intraluminal NK-mediated  tumor cell clearance and enhance extravasation of disseminated carcinoma cells,” Cancer Discov (2016 June; (6): 630-49)

MIT – Ludwig Graduate Student Fellowship

1L Leadership Council on Legal Diversity (LCLD) Scholars Program

2020 NY IP Law Education Foundation (NYIPLEF) Diversity Scholarship

Focus Areas
Education

J.D., Columbia Law School (2021)


Ph.D., Biology, Massachusetts Institute of Technology (2016)


B.S. summa cum laude, Biochemistry, King's College London (2010)


B.A.C. with high honors, Lycée Pierre de Fermat (2006)

Admissions
  • U.S. Patent and Trademark Office 2018
  • New York
Languages
  • English
  • German
  • French
  • Dutch
Memberships & Affiliations

NYIPLA Young Lawyers Committee (Co-Chair Spring 2021-present)
Member, New York IP Law Association (NYIPLA)
Member, ChIPs New York Chapter & Munich Chapter

What's trending with Jasmine

TOP